123 related articles for article (PubMed ID: 30942396)
1. lncRNA AWPPH promotes proliferation and inhibits apoptosis of non‑small cell lung cancer cells by activating the Wnt/β‑catenin signaling pathway.
Song Z; Du J; Zhou L; Sun B
Mol Med Rep; 2019 May; 19(5):4425-4432. PubMed ID: 30942396
[TBL] [Abstract][Full Text] [Related]
2. LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β‑catenin signaling pathway.
Yu G; Wang W; Deng J; Dong S
Mol Med Rep; 2019 May; 19(5):3615-3621. PubMed ID: 30896797
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA AWPPH Promotes Postoperative Distant Recurrence in Resected Non-Small Cell Lung Cancer by Upregulating Transforming Growth Factor beta 1 (TGF-β1).
Tang L; Wang T; Zhang Y; Zhang J; Zhao H; Wang H; Wu Y; Liu K
Med Sci Monit; 2019 Apr; 25():2535-2541. PubMed ID: 30953582
[TBL] [Abstract][Full Text] [Related]
4. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
6. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
[TBL] [Abstract][Full Text] [Related]
8. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
9. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis.
Li C; Wang F; Wei B; Wang L; Kong D
Biochem Biophys Res Commun; 2019 Jun; 514(3):1017-1022. PubMed ID: 31092328
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
11. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
[TBL] [Abstract][Full Text] [Related]
12. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
Fang J; Sun CC; Gong C
Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract][Full Text] [Related]
15. LncRNA AWPPH promotes the growth of triple-negative breast cancer by up-regulating frizzled homolog 7 (FZD7).
Wang K; Li X; Song C; Li M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30333256
[No Abstract] [Full Text] [Related]
16. Highly expressed lncRNA LOC730101 promotes lung cancer cell growth through Wnt canonical pathway.
Liu L; Zhang Y; Cao W
Biochem Biophys Res Commun; 2017 Nov; 493(2):992-997. PubMed ID: 28943432
[TBL] [Abstract][Full Text] [Related]
17. LncRNA GASL1 inhibits tumor growth of non-small cell lung cancer by inactivating TGF-β pathway.
Su WZ; Yuan X
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7282-7288. PubMed ID: 30468472
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
Xia Y; He Z; Liu B; Wang P; Chen Y
Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway.
Sun SJ; Lin Q; Ma JX; Shi WW; Yang B; Li F
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):504-510. PubMed ID: 28239820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]